Apogee Therapeutics, Inc. (APGE)
135.07
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
Apogee Therapeutics 1 Year Total Returns (Daily) : 262.4% for Sept. 11, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 11, 2026 | 262.4% |
| September 10, 2026 | 260.3% |
| September 09, 2026 | 251.2% |
| September 08, 2026 | 251.6% |
| September 04, 2026 | 263.8% |
| September 03, 2026 | 254.0% |
| September 02, 2026 | 256.8% |
| September 01, 2026 | 271.4% |
| August 31, 2026 | 271.4% |
| August 28, 2026 | 268.6% |
| August 27, 2026 | 257.1% |
| August 26, 2026 | 256.4% |
| August 25, 2026 | 265.1% |
| August 24, 2026 | 252.2% |
| August 21, 2026 | 270.7% |
| August 20, 2026 | 274.1% |
| August 19, 2026 | 270.0% |
| August 18, 2026 | 264.7% |
| August 17, 2026 | 260.9% |
| August 14, 2026 | 253.0% |
| August 13, 2026 | 259.9% |
| August 12, 2026 | 266.6% |
| August 11, 2026 | 288.7% |
| August 10, 2026 | 280.5% |
| August 07, 2026 | 274.6% |
| Date | Value |
|---|---|
| August 06, 2026 | 270.3% |
| August 05, 2026 | 250.2% |
| August 04, 2026 | 260.3% |
| August 03, 2026 | 255.3% |
| July 31, 2026 | 250.5% |
| July 30, 2026 | 257.1% |
| July 29, 2026 | 253.8% |
| July 28, 2026 | 238.3% |
| July 27, 2026 | 229.0% |
| July 24, 2026 | 222.5% |
| July 23, 2026 | 230.9% |
| July 22, 2026 | 238.6% |
| July 21, 2026 | 243.1% |
| July 20, 2026 | 241.3% |
| July 17, 2026 | 243.6% |
| July 16, 2026 | 249.4% |
| July 15, 2026 | 261.6% |
| July 14, 2026 | 244.5% |
| July 13, 2026 | 250.9% |
| July 10, 2026 | 246.5% |
| July 09, 2026 | 260.8% |
| July 08, 2026 | 266.0% |
| July 07, 2026 | 240.3% |
| July 06, 2026 | 181.3% |
| July 02, 2026 | 199.9% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 178.8% |
| Intellia Therapeutics, Inc. | 2.80% |
| Cogent Biosciences, Inc. | 160.8% |
| Revolution Medicines, Inc. | 340.7% |
| Moderna, Inc. | 467.0% |